Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: A long-term retrospective cohort study

BMC Gastroenterology

Volumn 7, Issue , 2007, Pages

  Actis, Giovanni C ^a   Fadda, Maurizio ^a   David, Ezio ^b   Sapino, Anna ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MESALAZINE; STEROID; CYCLOSPORIN; PREDNISOLONE;

ADULT; ARTICLE; BILIARY TRACT DISEASE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE INTERVAL; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FISHER EXACT TEST; GINGIVA HYPERPLASIA; HUMAN; HYPERTRICHOSIS; KAPLAN MEIER METHOD; LIVER FUNCTION TEST; LUNG EMBOLISM; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; RELAPSE; SEIZURE; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT DURATION; TREMOR; ULCERATIVE COLITIS; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; COLON RESECTION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG RESISTANCE; FOLLOW UP; HOSPITALIZATION; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; PROBABILITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREDNISOLONE; PROBABILITY; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247181314     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-7-13     Document Type: Article

References (22)

1. Lichtiger S Present DH Preliminary report: Cyclosporin in treatment of severe active ulcerative colitis Lancet 1990, 336:16-19. 10.1016/ 0140-6736(90)91521-B 1973211
2. Truelove SC Willoughby CP Lee EG Kettlewell MG Further experience in the treatment of severe attacks of ulcerative colitis Lancet 1978, 2:1086-1088. 10.1016/S0140-6736(78)91816-0 82099
3. Lichtiger S Present DH Kornbluth A Gelernt I Bauer J Galler G Michelassi F Hanauer S Cyclosporin in severe ulcerative colitis refractory to steroid therapy New Engl J Med 1994, 330:1841-1845. 10.1056/ NEJM199406303302601 8196726
4. Moskowitz D Vanassche G Maenhout B Arts J Ferrante M Vermeire S Rutgeerts P Incidence of colectomy during long-term follow-up after CsA- induced remission of severe ulcerative colitis Clinical Gastroenterology and Hepatology 2006, 4:760-765. 10.1016/j.cgh.2006.04.001
5. Cohen RD Stein R Hanauer SB Intravenous cyclosporin in ulcerative colitis: A five-year experience Am J Gastroenterol 1999, 94:1587-1592. 10.1111/j.1572-0241.1999.01149.x 10364029
6. Campbell S Travis S Jewell D Cyclosporin use in acute ulcerative colitis: A long-term experience Eur J Gastroenterol Hepatol 2005, 17:79-84. 10.1097/00042737-200501000-00016 15647646
7. Rayner CK McCormack G Emmanuel AV Kamm MA Long-term results of low-dose intravenous cyclosporin for acute severe ulcerative colitis Aliment Pharmacol Ther 2003, 18:303-308. 10.1046/j.1365-2036.2003.01618.x 12895214
8. Chung PY Cohen RD Kirschner BS Hanauer SB Intravenous cyclosporin in ulcerative colitis: Long-term follow-up of the University of Chicago experience [abstract] Am J Gastroenterol 2003, 98:S255 10.1016/ S0002-9270(03)01540-5
9. Segoloni GP Triolo G Squiccimarro G Colla L Turello E Aimo G Pecchio F Vercellone A Tailoring cyclosporin according to kinetic profiles: Does it allow a low-dose therapeutic schedule? Transplant Proc 1987, 19:1726-1727. 3274416
10. Rachmilewitz D Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial BMJ 1989, 298:82-86. 1835436 2563951
11. Actis GC Aimo G Priolo G Moscato D Rizzetto M Pagni R Efficacy and efficiency of oral microemulsion cyclosporin vs intravenous and soft-gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: An open-label retrospective trial Inflamm Bowel Dis 1998, 4:276-279. 10.1002/ibd.3780040404 9836079
12. Actis GC Ciancio A Lagget M Marzano A Ottobrelli A Ponti V Torrani-Cerenzia MR Rizzetto M Intravenous and oral cyclosporin in refractory ulcerative colitis: Toxicity in a low-dose trial [abstract] Gastroenterology 1997, 112:A919.
13. Hegde M Basavaraju KP Ahluwalia NK IV Cyclosporin for steroid-refractory acute ulcerative colitis is now available for prime-time use: Audit of a single unit's experience [abstract] Aliment Pharmacol Ther 2005. 21:198.
14. Actis GC Ottobrelli A Pera A Barletti C Ponti V Pinna-Pintor M Verme G Continuously infused cyclosporin at low-dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids J Clin Gastroenterol 1993, 17:10-13. 10.1097/ 00004836-199307000-00004 8409289
15. VanAssche G D'Haens G Noman M Vermeire S Hiele M Asnong G Arts J D'Hoore A Penninckx F Rutgeerts P Randomized-double-blind comparison of 4 mg/kg vs 2 mg/kg intravenous cyclosporine in severe ulcerative colitis Gastroenterology 2003, 125:1025-1031. 10.1016/S0016-5085(03)01214-9 14517785
16. Sternthal J George A Kornbluth A Lichtiger S Present DH Toxicity associated with the use of cyclosporin in patients with inflammatory bowel disease [abstract] Gastroenterology 1996, 110:A1019.
17. Durai D Hawthorne AB Review article: How and when to use cyclosporin in ulcerative colitis Aliment Pharmacol Ther 2005, 22:907-916. 10.1111/ j.1365-2036.2005.02680.x 16268964
18. Feagan BG Greenberg GR Wild G Fedorak RN Pare P McDonald JW Dube R Cohen A Steinhart AH Landau S Aguzzi RA Fox IH Vandervoort MK Treatment of ulcerative colitis with a humanized antibody to the alpha-4, beta-7 integrin New Engl J Med 2005, 352:2499-2507. 10.1056/NEJMoa042982 15958805
19. Rutgeerts P Sandborn WJ Feagan BG Reinisch W Olson A Johanns J Travers S Rachmilewitz D Hanauer SB Lichtenstein GR de Villiers WJ Present D Sands BE Colombel JF Infliximab for induction and maintenance therapy of ulcerative colitis N Engl J Med 2005, 353:2462-2476. 10.1056/ NEJMoa050516 16339095
20. Probert CS Hearing SD Schreiber S Kuhbacher T Ghosh S Arnott ID Forbes A Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: A randomized controlled trial Gut 2003, 52:998-1002. 10.1136/ gut.52.7.998 12801957
21. Järnerot G Hertervig E Friis Liby I Blomquist L Karlen P Granno C Vilien M Strom M Danielsson A Verbaan H Hellstrom PM Magnuson A Curman B Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized placebo-controlled study Gastroenterology 2005, 128:1805-1811. 10.1053/j.gastro.2005.03.003 15940615
22. Regueiro M Curtis J Plevy S Infliximab for hospitalized patients with severe ulcerative colitis J Clin Gastroenterol 2006, 40:476-481. 10.1097/ 00004836-200607000-00004 16825928